437 related articles for article (PubMed ID: 16555971)
1. Role of gemcitabine in cancer therapy.
Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
Future Oncol; 2005 Feb; 1(1):7-17. PubMed ID: 16555971
[TBL] [Abstract][Full Text] [Related]
2. [Gemcitabine: a new chemotherapy agent for solid cancers].
Klastersky J; Awada A
Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
[TBL] [Abstract][Full Text] [Related]
3. Development of gemcitabine in non-small cell lung cancer: the Italian contribution.
Metro G; Cappuzzo F; Finocchiaro G; Toschi L; Crinò L
Ann Oncol; 2006 May; 17 Suppl 5():v37-46. PubMed ID: 16807461
[TBL] [Abstract][Full Text] [Related]
4. [Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].
Azria D; Coelho M; Larbouret C; Lemanski C; Serre A; Ychou M; Pèlegrin A; Dubois JB; Culine S
Cancer Radiother; 2004 Nov; 8 Suppl 1():S106-13. PubMed ID: 15679255
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine: a pharmacologic and clinical overview.
Barton-Burke M
Cancer Nurs; 1999 Apr; 22(2):176-83. PubMed ID: 10217035
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine--a major advance?
Thomas A; Steward WP
Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
[No Abstract] [Full Text] [Related]
7. [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].
Gligorov J; André T; Epaud C; Culine S
Bull Cancer; 2002 Aug; 89 Spec No():S134-44. PubMed ID: 12449045
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine in non-small cell lung cancer.
Sørensen JB
Lung Cancer; 1995 Apr; 12 Suppl 1():S173-5. PubMed ID: 7551926
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine for lung cancer.
Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
[No Abstract] [Full Text] [Related]
10. Gemcitabine. New first-line therapy for pancreatic cancer.
King RS
Cancer Pract; 1996; 4(6):353-4. PubMed ID: 9128490
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine.
Prendiville J; O'Brien M
Br J Hosp Med; 1997 Apr 16-May 6; 57(8):405-9. PubMed ID: 9274666
[TBL] [Abstract][Full Text] [Related]
12. [Current status and future directions of gemcitabine in the treatment of non-small cell lung cancer and pancreatic cancer].
Yokoyama A
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1294-300. PubMed ID: 10945029
[TBL] [Abstract][Full Text] [Related]
13. [An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II].
Fukuoka M; Noda K; Hasegawa K; Nakajima H; Furuse K; Hirabayashi K; Hasegawa K; Ogura T; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1813-24. PubMed ID: 8937492
[TBL] [Abstract][Full Text] [Related]
14. Severe neurotoxicity caused by gemcitabine treatment.
Larsen FO; Hansen SW
Acta Oncol; 2004; 43(6):590-1. PubMed ID: 15370618
[No Abstract] [Full Text] [Related]
15. New-onset congestive heart failure with gemcitabine in ovarian and other solid cancers.
Shrum KJ; Gill SE; Thompson LK; Blackhurst DW; Puls LE
Am J Clin Oncol; 2014 Aug; 37(4):364-8. PubMed ID: 23357971
[TBL] [Abstract][Full Text] [Related]
16. Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine. San Antonio Drug Development Team.
Von Hoff DD
Invest New Drugs; 1996; 14(3):265-70. PubMed ID: 8958181
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine in non-small cell lung cancer.
Crinò L; Cappuzzo F
Expert Opin Pharmacother; 2002 Jun; 3(6):745-53. PubMed ID: 12036414
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.
Noble S; Goa KL
Drugs; 1997 Sep; 54(3):447-72. PubMed ID: 9279506
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study.
Bianco V; Rozzi A; Tonini G; Santini D; Magnolfi E; Vincenzi B; D'Angelillo R; Marchei P
Anticancer Res; 2002; 22(5):3053-6. PubMed ID: 12530041
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993.
Anticancer Drugs; 1995 Dec; 6 Suppl 6():5-65. PubMed ID: 8718418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
